You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 3, Issue 5

May 2010 - 25 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (25)

  • Review
  • Open Access
16 Citations
16,777 Views
14 Pages

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?

  • Mahir Karakas and
  • Wolfgang Koenig

29 April 2010

Based on the complex pathophysiology of atherosclerosis, a large number of biomarkers that relate to lipids, inflammation, immunity, thrombosis and hemostasis, have been investigated experimentally, in epidemiologic studies and in clinical trials. In...

  • Review
  • Open Access
34 Citations
22,441 Views
7 Pages

28 April 2010

NSAIDs provide optimal analgesia in renal colic due to the reduction in glomerular filtration and renal pelvic pressure, ureteric peristalsis and ureteric oedema. Prevention of glomerular afferent arteriolar vasodilatation renders these patients at r...

  • Review
  • Open Access
54 Citations
18,834 Views
24 Pages

28 April 2010

ATR is an apical kinase in one of the DNA-damage induced checkpoint pathways. Despite the development of inhibitors of kinases structurally related to ATR, as well as inhibitors of the ATR substrate Chk1, no ATR inhibitors have yet been developed. He...

  • Review
  • Open Access
21 Citations
11,977 Views
10 Pages

27 April 2010

Cyclooxygenase and lipoxygenase, two important enzymes involved in arachidonic acid metabolism, are major targets of non-steroidal anti-inflammatory drugs (NSAIDs). Recent investigations suggest that arachidonic cascades and their metabolites may be...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247